Skip to Content

APO 096 (Doxazosin 8 mg)

Pill imprint APO 096 has been identified as Doxazosin mesylate 8 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxazosin mesylate 8 mg APO 096
Doxazosin mesylate 8 mg APO 096
Doxazosin mesylate 8 mg APO 096 Front
Doxazosin mesylate 8 mg APO 096 Back
Doxazosin mesylate 8 mg APO 096
Doxazosin mesylate
APO 096
8 mg
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Apotex Corp.
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-5525 Major Pharmaceuticals
42291-0260 AvKare, Inc.
54868-4767 Physicians Total Care Inc (repackager)
67544-0325 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.